| Product NDC: | 50111-884 |
| Proprietary Name: | Metronidazole |
| Non Proprietary Name: | Metronidazole |
| Active Ingredient(s): | 375 mg/1 & nbsp; Metronidazole |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 50111-884 |
| Labeler Name: | Pliva |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA076522 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20090930 |
| Package NDC: | 50111-884-05 |
| Package Description: | 50 CAPSULE in 1 BOTTLE (50111-884-05) |
| NDC Code | 50111-884-05 |
| Proprietary Name | Metronidazole |
| Package Description | 50 CAPSULE in 1 BOTTLE (50111-884-05) |
| Product NDC | 50111-884 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Metronidazole |
| Dosage Form Name | CAPSULE |
| Route Name | ORAL |
| Start Marketing Date | 20090930 |
| Marketing Category Name | ANDA |
| Labeler Name | Pliva |
| Substance Name | METRONIDAZOLE |
| Strength Number | 375 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Nitroimidazole Antimicrobial [EPC],Nitroimidazoles [Chemical/Ingredient] |